Cabaletta Bio, Inc. CABA
2.07
(0.09)
(4.17%)
as of 25 Sep
- Market cap
- $373.0M
- P/E
- 0.0×
Follow CABA
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.77 | 6.15 | 15.29 | 11.47 | 14.86 | 21.92 | 44.66 | 36.05 | 0.00 |
Net Debt/EBITDA |
0.84 | 1.35 | 3.26 | 2.03 | 2.69 | 3.26 | 7.33 | 5.33 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.78 | 0.76 | 0.79 | 0.88 | 0.74 | 0.80 | 0.72 | 0.38 | 0.00 |
Capex/Depreciation |
(0.10) | (0.60) | (1.12) | (1.50) | (1.47) | (1.34) | (6.66) | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (126.98%) | (59.64%) | (39.72%) | (47.62%) | (40.69%) | (26.90%) | (34.90%) | 223.09% | 4.57% | |
| (95.88%) | (52.82%) | (36.52%) | (43.55%) | (38.40%) | (26.03%) | (25.36%) | (71.41%) | (1.46%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (2,397.46%) | (551.58%) | (1,808.70%) | 0.00% |
Return on Tangible Assets |
(185.19%) | (81.40%) | (29.29%) | (51.98%) | (39.36%) | (30.52%) | (16.11%) | (36.92%) | 100.40% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Free Cash Flow per Share |
(1.66) | (1.84) | (1.38) | (1.88) | (1.65) | (1.57) | (3.85) | (4.15) | 0.00 |
Cash per Share |
1.67 | 3.34 | 6.16 | 4.10 | 5.72 | 6.24 | 31.34 | 29.37 | 0.00 |
Shareholders Equity per Share |
1.40 | 3.11 | 6.03 | 4.02 | 5.52 | 6.29 | 31.83 | 29.56 | (0.01) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.40 | 3.11 | 6.03 | 4.02 | 5.52 | 6.29 | 31.83 | 29.56 | (0.01) |
Free Cash Flow |
(132.31) | (90.43) | (54.24) | (48.83) | (35.27) | (27.40) | (16.74) | (4.66) | — |
Working Capital |
88.72 | 139.59 | 228.50 | 99.35 | 116.16 | 108.36 | 137.41 | 33.05 | (0.25) |
Capital Expenditures |
(1.23) | (2.21) | (0.69) | (2.45) | (1.17) | (0.63) | (0.69) | — | — |
Net Current Asset Value |
85.84 | 133.96 | 227.04 | 96.39 | 116.16 | 108.36 | 137.41 | 33.05 | (0.25) |
| Other line items | |||||||||
Quick Ratio |
2.66 | 6.05 | 15.08 | 11.23 | 14.59 | 20.98 | 43.28 | 35.01 | 0.00 |
Depreciation/Fixed assets |
6.41 | 1.35 | 0.24 | 0.64 | 0.55 | 0.53 | 0.13 | — | — |
Cash ROIC |
(54.14%) | (28.76%) | (11.75%) | (23.20%) | (14.80%) | (12.68%) | (6.14%) | (7.04%) | 0.00% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.64) | (1.80) | (1.37) | (1.78) | (1.60) | (1.54) | (3.69) | (4.15) | 0.00 |
Capex per Share |
(0.02) | (0.05) | (0.02) | (0.09) | (0.05) | (0.04) | (0.16) | 0.00 | 0.00 |
Average Payables |
5.78 | 4.74 | 3.51 | 2.40 | 1.79 | 1.08 | 0.76 | 0.40 | 0.40 |
Average Assets |
175.06 | 219.35 | 185.31 | 121.65 | 120.53 | 128.10 | 87.82 | 17.09 | 17.09 |
Average Common Equity |
132.19 | 194.27 | 170.36 | 111.24 | 113.75 | 123.93 | 63.82 | (5.47) | (5.47) |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates